DRKS00003203
Recruiting
Not Applicable
on-interventional study on the safety and efficacy of an Abraxane(R) mono therapy for the therapy of patients with metasasized breast cancer with special consideration of the toxicity profiles - Abraham study
OnkoDataMed GmbH !0 sites450 target enrollmentJuly 26, 2011
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C50
- Sponsor
- OnkoDataMed GmbH !
- Enrollment
- 450
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Secured metastasized breast cancer with at least 1 metastasis (by means of RECIST or diffuse metastasis of the skeloton)
- •Gender: female
- •Alge: \=18 ýears
- •Signed patient informed consent
- •Therapy in a practice which is member of the BNGO
- •Adequate general condition \= 2 on the ECOG Scale
- •Adequate bone marrow reserves: number of neutrophiles \< 1,5 x 1E9 /L before start of the therapy
Exclusion Criteria
- •Pregnancy and lactation
- •Lack of compliance
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
on-interventional study about safety and efficacy of chemo-therapy with Paclitaxel Stragen(R) / Eurotaxel(R) (new name of the prescription) as mono or combined therapy for routine treatment of ovarial or breast cancer with special consideration of age and BMI starting position.Breast cancer, ovarial cancerDRKS00000781apharm GmbH1,500
Not yet recruiting
Phase 3
A randomized control trial to study the antibody response and side effects after the booster dose of COVID-19 vaccineCTRI/2022/01/039677Institute of Liver and Biliary Sciences
Completed
Phase 3
BS054 Clinical StudyJPRN-jRCT2092220032Boston Scientific Japan K.K.20
Completed
Phase 2
se of Roselle in Bronchial asthma and MalnutritioHealth Condition 1: J454- Moderate persistent asthmaCTRI/2020/08/027013DXN Manufacturing India Pvt Ltd12
Completed
Phase 2
se of Noni juice in Bronchial asthma and malnutritioHealth Condition 1: J454- Moderate persistent asthmaCTRI/2020/08/027012DXN Manufacturing India Pvt Ltd12